Analyst firms · UBS · MDB
UBS MDB price target and rating history
MongoDB Inc. (MDB) · Technology
UBS rates MongoDB Inc. (MDB) Neutral with a $410 price target, as of its latest action on Jan 4, 2024. It has published 3 rating actions on MDB since September 2021, including 1 upgrade and 1 downgrade. Across 8 firms with a MDB price target in the last 12 months, the median target is $410.
- Current rating
- Neutral
- Price target
- $410
- Median target, all firms
- $410
- Actions on MDB
- 3
UBS price target on MDB
Every UBS rating on MDB
- Jan 4, 2024
- Mar 18, 2022
- Sep 3, 2021
How other firms rate MDB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $420 | Sep 30, 2026 |
| Monness, Crespi, Hardt | Buy | $500 | Sep 2, 2026 |
| Evercore ISI | Outperform | $525 | Aug 21, 2026 |
| Needham | Buy | $430 | Jul 10, 2026 |
| Mizuho | Outperform | $325 | Mar 23, 2026 |
| Scotiabank | Sector Outperform | $310 | Mar 5, 2026 |
| Robert W. Baird | Neutral | $260 | Mar 3, 2026 |
| Raymond James | Mkt Perform | Dec 16, 2025 | |
| Guggenheim | Neutral | $400 | Nov 18, 2025 |
Questions about UBS and MDB
- What is UBS's price target for MDB?
- UBS's latest stated price target for MongoDB Inc. (MDB) is $410, from its action on Jan 4, 2024.
- What is UBS's rating on MDB?
- UBS rates MDB Neutral, a neutral rating, as of Jan 4, 2024.
- When did UBS last change its view on MDB?
- On Jan 4, 2024, UBS downgrades to Neutral from Buy, price target $475 to $410.
- How does UBS's MDB target compare with other analysts?
- Across 8 firms with a MDB price target in the last 12 months, the median target is $410.
More MDB rating histories
- BMO Capital Markets8
- Monness, Crespi, Hardt9
- Needham6
- Mizuho6
- Guggenheim5
- Wells Fargo3
- Rothschild & Co Redburn4
- Citigroup3
- Morgan Stanley6
- Credit Suisse3
- Canaccord Genuity3
- Barclays4
All UBS ratingsMDB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.